Downregulation of reelin predicts poor prognosis for glioma.

In the present study, we studied the relationship between and prognosis in glioma. Expression profiles and methylation data of were obtained from bioinformatic datasets. Correlations between and clinicopathological features and overall survival were respectively assessed using chi-square test and Kaplan-Meier analysis.

Overexpression of high mobility group box 1 (HMGB1) has no correlation with the prognosis in glioma.

We aimed to characterize the role of HMGB1 overexpression in glioma and to evaluate its use as a biomarker. We used the gene expression datasets and tissue microarray to assess the expression levels of HMGB1 among gliomas of all grades; We then assessed its correlation with the malignancy and outcome of glioma. The increase in HMGB1 mRNA and protein levels was found in glioma, but there was no correlation between HMGB1 expression and glioma malignancy, and overall survival and vital status of glioma patients.